Case Report
Accepted on 25 Jul 2025
Trastuzumab deruxtecan for the treatment of metastatic non-small cell lung cancer harboring HER2 non-exon 19/20 mutations: A case series
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 25 Jul 2025
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 25 Jul 2025
in Neurorehabilitation
Review
Accepted on 25 Jul 2025
in Neurorehabilitation
Mini Review
Accepted on 25 Jul 2025
in Psychological Therapy and Psychosomatics
Editorial
Accepted on 25 Jul 2025
in Microbes and Innate Immunity
Editorial
Accepted on 25 Jul 2025
in Big Data Networks
Original Research
Accepted on 25 Jul 2025
in Green and Sustainable Chemistry
Original Research
Accepted on 25 Jul 2025
in Clinical and Diagnostic Microbiology and Immunology
Original Research
Accepted on 25 Jul 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 25 Jul 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Jul 2025
in Veterinary Humanities and Social Sciences
Original Research
Accepted on 25 Jul 2025
in Veterinary Emergency and Critical Care Medicine
Retraction
Accepted on 25 Jul 2025
in Molecular Signalling and Pathways
Case Report
Accepted on 25 Jul 2025
in Pulmonary Medicine
Original Research
Accepted on 25 Jul 2025
in Pharmacoepidemiology
Mini Review
Accepted on 25 Jul 2025
in Cancer Immunity and Immunotherapy